Subscribe
11 March 2025NewsCareersTom Phillips

Blank Rome bolsters patent litigation with Houston partner hire

The ex-Cadwell Clonts Reeder & Thomas trial attorney and litigator represents clients in all phases of litigation in both federal and state courts, bringing particular experience of disputes in the Eastern and Southern Districts of Texas.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Careers
Jones Day adds experienced patent litigators from Weil
4 March 2025   Based in Silicon Valley and San Francisco, the duo bring experience in patent litigation across life sciences, biotechnology, and high technology, including a recent victory overturning a $96 million jury verdict in an organ transplant testing case.
Careers
Amy Candido to head IP litigation team at Simpson Thacher
28 February 2025   Candido, widely recognised as a highly skilled trial lawyer, will augment the firm’s capabilities in the technology and life sciences spaces.


Editor's picks

Killing the golden goose of US drug innovation (Part II): Drug pricing myths
Americas
Killing the golden goose of US drug innovation (Part II): Drug pricing myths
12 September 2025

Editor's picks

Americas
Killing the golden goose of US drug innovation (Part II): Drug pricing myths
12 September 2025
Americas
Smart ringleader: Could Ōura’s market dominance be under threat?
5 September 2025
Americas
Why Masimo’s ‘rare’ move pushes Apple case into uncharted territory
3 September 2025
Europe
Sandoz blocked by UK court from seeking Xarelto profits
2 September 2025
Europe
UPC sees rising small molecule litigation with Pfizer in the hot seat
29 August 2025
Europe
Astellas win strengthens blockbuster drug's European position
20 August 2025

More features

To disclose or not: Pharma patents face new AI reality
Trade secrets go global: How brand owners face a high-stakes battlefront
Killing the golden goose of US drug innovation (Part II): Drug pricing myths
Former pharma GC brings in-house perspective to McGuireWoods
Sandoz eyes US biosimilar launch as Regeneron settles
Killing the golden goose of US drug innovation (Part I): Follow the money
Buchalter brings in new partner to head up medtech
Trump’s march-in rights threat: Why pharma is rethinking collaborations